Opening book details…
Can I read Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020 on EtoBox?
Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020 by Julia Liaw; Meera Harhay; Soko Setoguchi; Tobias Gerhard; Chintan V. Dave is a Medicine article available to read on EtoBox.
What is Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020 about?
## Objective: To evaluate trends in antidiabetic medication initiation patterns among patients with type 2 diabetes mellitus (t2dm) with and without chronic kidney disease (ckd). ## Research design and methods: A retrospective cohort study using the uk clinical practice research datalink (2006-2020) was conducted to evaluate the overall, first-, and second line (after metformin) medication initiation patterns among patients with ckd (n = 38,622) and those without ckd (n = 230,963) who had t2dm. ## Results: Relative to other glucose-lowering therapies, metformin initiations declined overall but remained the first-line treatment of choice for both patients with and those without ckd. sodium-glucose cotransporter-2 (sglt2i) use increased modestly among patients with ckd, but this increase was more pronounced among patients without ckd; by 2020, patients without ckd, compared with patients with ckd, were three (28.5% vs. 9.4%) and six (46.3% vs. 7.9%) times more likely to initiate sglt2i overall and as second-line therapy, respectively. glucagon-like peptide 1 receptor agonist (glp-1ra) use was minimal regardless of ckd status (<5%), whereas both dipeptidyl peptidase-4 inhibitor (dpp4i
Who reads Trends in Prescribing Preferences for Antidiabetic Medications Among Patients With Type 2 Diabetes in the U.K. With and Without Chronic Kidney Disease, 2006–2020?
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Julia Liaw; Meera Harhay; Soko Setoguchi; Tobias Gerhard; Chintan V. Dave
- Published
- 2022
- Language
- EN
- Field
- Medicine (Health Sciences)
More by Julia Liaw; Meera Harhay; Soko Setoguchi; Tobias Gerhard; Chintan V. Dave
Browse all works by Julia Liaw; Meera Harhay; Soko Setoguchi; Tobias Gerhard; Chintan V. Dave